Literature DB >> 25695228

Reply to "Pulmonary metastasectomy: where is the evidence?": absence of evidence is not evidence of absence!

Paul E Van Schil1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25695228     DOI： 10.1097/JTO.0000000000000451

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  2 in total

1.  Toripalimab combined with docetaxel and cisplatin neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a single-center, single-arm clinical trial (ESONICT-2).

Authors:  Lei Gao; Jieming Lu; Peipei Zhang; Zhi-Nuan Hong; Mingqiang Kang
Journal:  J Gastrointest Oncol       Date:  2022-04

2.  A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909).

Authors:  Yan Zheng; Xian-Ben Liu; Hai-Bo Sun; Jinliang Xu; Sining Shen; Yu-Feng Ba; Ming Yan; Zimin Qin; Bao-Xing Liu; Zong-Fei Wang; Shi-Lei Liu; Rui-Xiang Zhang; Pei-Nan Chen; Guang-Hui Liang; Dongfeng Yuan; Zhen-Xuan Li; Qi Liu; Hao-Ran Wang; Hao-Miao Li; Hongwei Lv; Xiaochao Ma; Jianping Zhu; Yong-Kui Yu; Wen-Qun Xing
Journal:  Ann Transl Med       Date:  2021-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.